Search Thermo Fisher Scientific
Reconstitute in 100 µL of sterile water. Centrifuge to remove any insoluble material.
The antigen is homologous in human.
Specificity of this antibody: Laforin.
The Epilepsy, progressive myoclonus type 2A protein (EPM2A) is a dual-specificity phosphatase that associates with polyribosomes. Mutations in this gene have been associated with myoclonic epilepsy of Lafora. EPM2A interacts with a number of proteins known to be involved in glycogen metabolism and has been shown to have robust phosphatase activity against a phosphorylated complex carbohydrate, suggesting that EPM2A may be involved in the regulation of glycogen metabolism.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: epilepsy, progressive myoclonus type 2, Lafora disease (laforin); EPM2A; Glucan phosphatase; Glycogen phosphatase; Lafora PTPase; Laforin; LAFPTPase; RP1-28C20.2
基因别名: EPM2; EPM2A; MELF; Tg(TcraK,TcrbK)TG-BFlv; TG-B
UniProt ID: (Human) O95278, (Mouse) Q9WUA5
Entrez Gene ID: (Human) 7957, (Mouse) 13853